KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

News: KZA Kazia Therapeutics Says U.S. FDA Grants Rare Pediatric Disease Designation To Paxalisib

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    07/08/20
    10:05
    Post #: 46369499

    Aug 7 (Reuters) - Kazia Therapeutics Ltd (KZA) :

    • US FDA GRANTS RARE PEDIATRIC DISEASE DESIGNATION TO PAXALISIB FOR DIFFUSE INTRINSIC PONTINE GLIOMA
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Revised model reveals high-grade gold/copper potential at El Dovio—find out what’s been uncovered
right-arrow Created with Sketch.
NEWS Kathleen Valley’s first spodumene shipment departs—see how this company is advancing fast
right-arrow Created with Sketch.
NEWS New insights revealed: high-grade lode gold/copper deposit model for El Dovio Project reinterpreted—see the potential
right-arrow Created with Sketch.
EBR FDA commences substantive review of EBR’s PMA application
right-arrow Created with Sketch.
NEWS Major acquisition of high-grade antimony deposit, find out who's securing global assets
right-arrow Created with Sketch.
LU7 Strong preliminary feasibility for Bécancour Lithium Refinery
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.